Catalent | CTLT - Loan Capital


Catalent reported $0 in Loan Capital for its fiscal quarter ending in September of 2024.



Loan Capital Change Date
Agilent USD 3.05B 300M Sep/2025
AstraZeneca USD 26.14B 19.58B Dec/2025
Bristol-Myers Squibb USD 42.85B 1.62B Dec/2025
Bruker USD 1.85B 131.7M Dec/2025
Centene USD 17.35B 194M Dec/2025
Charles River Laboratories USD 2.19B 146.92M Sep/2025
Cigna USD 30.95B 4.47B Sep/2025
Danaher USD 18.42B 1.58B Dec/2025
Dentsply International USD 2.02B 201M Sep/2025
Elevance Health USD 30.8B 376M Dec/2025
Eli Lilly USD 40.87B 5.6M Dec/2025
Glaxosmithkline GBP 20.02B 4.72B Sep/2025
Hologic USD 2.5B 2.1M Dec/2025
Humana USD 12.37B 238M Dec/2025
Illumina USD 1.49B 496M Dec/2025
Intuitive Surgical USD 0 0 Mar/2025
IQVIA Holdings USD 13.88B 1.09B Dec/2025
J&J USD 39.44B 30M Dec/2025
Laboratory Of America USD 5.15B 3.9M Sep/2025
Lonza CHF 4.24B 602M Dec/2024
McKesson USD 5.43B 586M Dec/2025
Merck EUR 10.45B 4.15B Sep/2025
Merck USD 39.97B 6B Sep/2025
Mettler Toledo International USD 2.09B 58.01M Dec/2025
Novartis USD 24.24B 174M Sep/2025
Pfizer USD 57.41B 93M Sep/2025
Quest Diagnostics USD 5.17B 4M Dec/2025
Repligen USD 537.93M 4.2M Sep/2025
Revvity USD 2.63B 543K Dec/2025
Roche Holding CHF 27.43B 966M Dec/2025
Supernus Pharmaceuticals USD 400.38M 21.13M Mar/2022
Thermo Fisher Scientific USD 35.85B 4B Dec/2025
UnitedHealth USD 72.32B 79M Dec/2025
Waters USD 1.41B 460.24M Dec/2025
West Pharmaceutical Services USD 202.8M 100K Dec/2025